Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369] Draft guidance Technology appraisal guidance 2 April ...
The Wall Street Journal's Michelle Hackman tells NPR's Ayesha Rascoe about the "extreme vetting" tactics international visitors say U.S. border officials are employing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback